| |
| |
Contributors | |
| |
| |
Preface | |
| |
| |
Volumes in Series | |
| |
| |
| |
Chemokines and Receptors in Disease | |
| |
| |
| |
Chemokines in Human Breast Tumor Cells: Modifying Their Expression Levels and Determining Their Effects on the Malignancy Phenotype | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Modifying Chemokine Expression in Breast Tumor Cells | |
| |
| |
| |
Establishment of Primary Local Breast Tumors and Pulmonary Metastases | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
CCR5 Pharmacology Methodologies and Associated Applications | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
CCR5 Signaling Assays and Application to Quantify and Characterize Ligand-Dependent Agonism, Antagonism, and Inverse Agonism | |
| |
| |
| |
CCR5-Associated Ligand-Binding Assays | |
| |
| |
| |
Surrogate In Vitro Antiviral Assays | |
| |
| |
| |
CCR5 Site-Directed Mutagenesis and Ligand Docking Studies | |
| |
| |
| |
Non-HIV Indications-Associated Studies, Human CCR5 Knock-In Mice | |
| |
| |
References | |
| |
| |
| |
CXCR4 and Mobilization of Hematopoietic Precursors | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
HSPC Mobilizing Agents that Target the CXCL12/CXCR4 Axis | |
| |
| |
| |
Donor Selection for HSPC Mobilization | |
| |
| |
| |
Flow Cytometric Enumeration of Mobilized HSPCs | |
| |
| |
| |
Dosing and Kinetics of HSPC Mobilization by G-CSF and Plerixafor | |
| |
| |
| |
Flow Cytometric Analysis of CXCR4 Expression on Human CD34<sup>+</sup> Subsets | |
| |
| |
| |
Functional Characterization of Mobilized HSPCs | |
| |
| |
| |
Concluding Remarks | |
| |
| |
Acknowledgment | |
| |
| |
References | |
| |
| |
| |
Double-Label Nonradioactive In Situ Hybridization for the Analysis of Chemokine Receptor Expression in the Central Nervous System | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Basic Protocol for ISH (Using Digoxygenin-Labeled Probe) | |
| |
| |
| |
Comments | |
| |
| |
References | |
| |
| |
| |
Expression of Chemokines and Chemokine Receptors in Human Colon Cancer | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Materials and Methods | |
| |
| |
| |
Results | |
| |
| |
| |
Discussion | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Chemokine Related Proteins from Pathogens | |
| |
| |
| |
Kaposi's Sarcoma Virally Encoded, G-Protein-Coupled Receptor: A Paradigm for Paracrine Transformation | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Cloning of vGPCR | |
| |
| |
| |
Assaying vGPCR Transforming Activity In Vitro | |
| |
| |
| |
vGPCR Transforming Activity In Vivo Using Xenograft Systems | |
| |
| |
| |
In Vivo Targeted Infection Using the TVA-RCAS System | |
| |
| |
| |
vGPCR-Induced Paracrine Transformation | |
| |
| |
| |
Characterization of vGPCR-Induced Molecular Signaling | |
| |
| |
| |
Evaluation of Activation of Second-Messenger-Generating Systems | |
| |
| |
| |
Activation of Signal-Transducing Protein Kinases and Small GTPases | |
| |
| |
| |
Akt Kinase Assay | |
| |
| |
| |
vGPCR Stimulated Activation of Rac1-Pulldown Assays | |
| |
| |
| |
Western Blotting Using Phospho-Specific Antibodies | |
| |
| |
| |
Activation of Transcription Factors | |
| |
| |
| |
Global Changes in Gene Expression: Microarray Analysis | |
| |
| |
| |
NFkB Luciferase Assays | |
| |
| |
| |
NFkB Binding Assays | |
| |
| |
| |
Nuclear Translocation of NFkB | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Pharmacological and Biochemical Characterization of Human Cytomegalovirus-Encoded G Protein-Coupled Receptors | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Virally Encoded GPCR Engineering | |
| |
| |
| |
vGPCR Expression, Trafficking, and Radioligand Binding | |
| |
| |
| |
vGPCR-Induced Signal Transduction | |
| |
| |
| |
vGPCR-Induced Oncogenesis | |
| |
| |
| |
Generation of Recombinant HCMV Strains by Markerless Bacterial Artificial Chromosome Mutagenesis | |
| |
| |
| |
Conclusions | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Identification and Characterization of Virus-Encoded Chemokine Binding Proteins | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Methods for Studying Chemokine-Binding Proteins | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
The Chemokine-Binding Protein M3 as a Tool to Understand the Chemokine Network In Vivo | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Generation of Transgenic Mice Expressing M3 in Insulin-Producing b Cells | |
| |
| |
| |
M3 Expression in Islets of Langerhans Blocks CCL2-, CCL21-, and CXCL13-Induced Migration of Cells to Islets | |
| |
| |
| |
M3 Expression in b Cells Blocks Cellular Infiltration and Prevents Diabetes Development | |
| |
| |
| |
Generation of a Conditional Transgenic System for Expression of M3 | |
| |
| |
| |
Concluding Remarks | |
| |
| |
References | |
| |
| |
| |
M-T7: Measuring Chemokine-Modulating Activity | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Protein Expression | |
| |
| |
| |
Quantifying the Effects of M-T7 In Vitro and Ex Vivo | |
| |
| |
| |
Quantifying the Effects of M-T7 on Vascular Inflammatory Responses in Rodent Vascular Transplant Models | |
| |
| |
| |
Preclinical Toxicity Testing | |
| |
| |
References | |
| |
| |
| |
Atypical and Novel Chemoattractants and Receptors | |
| |
| |
| |
Role of the Chemokine Scavenger Receptor D6 in Balancing Inflammation and Immune Activation | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Methods | |
| |
| |
| |
Results | |
| |
| |
| |
Discussion | |
| |
| |
References | |
| |
| |
| |
Structure-Function Dissection of D6, an Atypical Scavenger Receptor | |
| |
| |
| |
| |
Introduction | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Modeling Small Molecule-Compound Binding to G-Protein-Coupled Receptors | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Similarity and Differences in the Crystal Structures of Class-A GPCRs Solved to Date | |
| |
| |
| |
GPCR Modeling Methods | |
| |
| |
| |
Computational Methods for Receptor Flexibility and Ligand-Induced Conformational Changes in GPCRs | |
| |
| |
| |
Validation of GPCR-Ligand Models | |
| |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Elucidation of Chemerin and Chemokine-Like Receptor-1 Function in Adipocytes by Adenoviral-Mediated shRNA Knockdown of Gene Expression | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
The 3T3-L1 Cell Model for Adipogenesis and Adipocyte Metabolism | |
| |
| |
| |
RNA Interference | |
| |
| |
| |
Methods for Adenoviral shRNA Knockdown of Chemerin and CMKLR1 in 3T3-L1 Cells | |
| |
| |
| |
Concluding Remarks | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Chemokine Signaling | |
| |
| |
| |
Characterization of Chemokine Receptor CXCR2 Interacting Proteins Using a Proteomics Approach to Define the CXCR2 "Chemosynapse" | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Validation of the Interaction of Novel Proteins with CXCR2 | |
| |
| |
| |
Mutational Analysis of Residues at Interactive Interface of CXCR2 and CXCR2-Binding Proteins | |
| |
| |
| |
Radioactive Phosphorylation of CXCR2 Interacting Proteins | |
| |
| |
| |
Chemotaxis Assay | |
| |
| |
| |
Conclusions | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Phosphoproteomic Analysis of Chemokine Signaling Networks | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Methods | |
| |
| |
| |
Summary | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Monitoring NF-kB Mediated Chemokine Transcription in Tumorigenesis | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Development of NF-kB Reporter Model for Tumors | |
| |
| |
| |
Bioluminescent Imaging of Intratumor Signaling of Anesthetized Mice | |
| |
| |
| |
Cell-Based Assays for Kinase and Transcriptional Activity In Vitro | |
| |
| |
| |
Peripheral Spying of Intratumoral Signaling of Conscious Mice | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Analysis of Chemokine Receptor Endocytosis and Intracellular Trafficking | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Receptor Detection | |
| |
| |
| |
Cells | |
| |
| |
| |
Monitoring Receptor Endocytosis | |
| |
| |
| |
Monitoring Receptor Recycling | |
| |
| |
| |
Monitoring Receptor Degradation | |
| |
| |
| |
Electron Microscopy Analysis of Receptor Internalization | |
| |
| |
Acknowledgments | |
| |
| |
References | |
| |
| |
| |
Measuring the Proximity of T-Lymphocyte CXCR4 and TCR by Fluorescence Resonance Energy Transfer (FRET) | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Assaying CXCR4-TCR Proximity via the PE/APC mAb FRET Approach | |
| |
| |
| |
Assaying CXCR4-TCR Proximity via the CFP/YFP Fusion Protein Approach | |
| |
| |
| |
Concluding Remarks | |
| |
| |
References | |
| |
| |
| |
Expression of CXCR4, a G-Protein-Coupled Receptor for CXCL12 in Yeast: Identification of New-Generation Inverse Agonists | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Methods and Discussion | |
| |
| |
| |
Summary | |
| |
| |
References | |
| |
| |
| |
Ubiquitination of Chemokine Receptors | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Cell Culture and Transfections | |
| |
| |
| |
Agonist Treatment and Ubiquitination Assay | |
| |
| |
| |
E3 Ubiquitin Ligase AIP4 Mediates Ubiquitination of CXCR4 | |
| |
| |
References | |
| |
| |
Author Index | |
| |
| |
Subject Index | |